In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Moderated Posters Awards

Presenters from abstracts selected for a presentation in a Moderated Posters session during ESC Congress are in competition for the best Moderated Poster.

Note in your agenda next abstract submission for ESC Congress: Early December to 14 February 2017, midnight CET.



Moderated Posters Awards 2016

Congratulations to the winners of the Moderated Posters Awards Sessions 2016 !

Overall winners by topics

 Prof. Oussama Wazni

Arrhythmias, Pacing, Resynchronisation: Cardiac implantable electronic device infection: variability in clinical presentation and outcomes in patients with or without previously abandoned leads

 Dr. Oscar Miro

Heart Failure, LV Dysfunction: Predictors of 30-day mortality in patients with acute heart failure at emergency department admission: derivation and validation of the MEESSI-AHF scale

 Dr. Alexander Egbe

Congenital, Valvular Myopericardial Diseases, Pulmonary Circulation: Outcomes in moderate mixed aortic valve disease: is it time for a paradigm shift?

 Dr. Jasper Boeddinghaus

Ischaemia, Coronary Artery Disease, Acute Cardiac Care, Acute Coronary Syndromes: Direct comparison of four very early rule-out strategies for acute myocardial infarction using high-sensitivity cardiac troponin I

 Dr. Pedro Canas da Silva

Interventions, Peripheral Circulation, Stroke, Surgery: Medtronic CoreValve vs Edwards Sapien: a comparative analysis of efficacy, safety and mortality from an eight year nationwide registry

 Prof. Christopher Paul Cannon

Prevention, Rehabilitation, Sports Cardiology, Nursing, Ageing: Modeling lipid-lowering therapy intensification in the real world: how many patients with atherosclerotic cardiovascular disease would need a PCSK9 inhibitor?

 Dr. Thomas Steen Gyldenstierne Sehested

Hypertension, Pharma: Dose-response relationship between proton pump inhibitor use and associated risk of myocardial infarction: a nationwide cohort study

 Dr. Christian Werner

Basic Science: Telomerase deficiency is associated with impaired diastolic function, mitochondrial dysfunction and increased fibrosis in a murine model of cardiac pressure overload

 Mr. Niklas Dyrby Johansen

Cardiac Imaging & e-Technology: Diastolic dysfunction revisited: a new, feasible and unambigious classification predicts major cardiovascular events

Winners by sessions

Tuesday 30 August - 15:00

 Ms. Nefissa Hammache

Common clinical applications of CMR: Relationship between the morphology of myocardial infarction scar border assessed by cardiac magnetic resonance and the inducibility of ventricular tachycardia

 Dr. Thomas Steen Gyldenstierne Sehested

Lipid-lowering agents - New perspectives: Dose-response relationship between proton pump inhibitor use and associated risk of myocardial infarction: a nationwide cohort study

 Assoc. Prof. Elfriede Ruttmann-Ulmer

Valve repair and assist devices: Long-term outcome of mitral valve repair versus replacement in a large series of patients with infective endocarditis

 Dr. Anna-Karin Nume

Management of syncope: Return to work is high following syncope: a nationwide study

 Assist. Prof. Kohei Yamamizu

Cell regenerative therapy: Human iPS cell-engineered 3D-cardiovascular tissue by stacking sheets with gelatin hydrogel microspheres for cardiac regenerative medicine

 Prof. Ping-Yen Liu

Cancer and cardiotoxicity: from bench to bedside: CCAAT/enhancer binding protein delta contributes to an earlier phase of pro-inflammatory response in doxorubicin related cardiomyopathy

 Dr. Andreia Pereira

Cardiovascular risk scores: novel tunes in a familiar music: Reclassification of the Intermediate group classified according to HEARTSCORE taking in consideration individual genetic predisposition to Coronary artery disease.

 Dr. Alexander Egbe

New insights in aortic valve stenosis: Outcomes in moderate mixed aortic valve disease: is it time for a paradigm shift?

 Dr. Reza Masoomi

Challenging preconceptions in acute coronary syndromes.: In-hospital management and outcomes in pregnancy associated acute myocardial infarction: results from the United States national inpatient sample database

 

Tuesday 30 August - 10:00

 Dr. Lida Khurrami

Novel clinical implications of cardiac CT: Association between aortic valve calcification quantified using non-contrast cardiac CT and aortic valve stenosis assessed by transthoracic echocardiography in the general 

 Assoc. Prof. Sarah Chua

Cardiomyopathy with preserved ejection fraction: Amyloidosis and hypertension: Impact of impaired cardiac function on the progression of chronic kidney disease---role of pharmacomodulation of valsartan

 Dr. Hironori Uzuka

Physiology of stenting from bench to bedside: Renal denervation suppresses coronary hyperconstricting responses after DES implantation in pigs in vivo  -Evidence for the kidney-brain-heart interactions

 Mr. Yann Xu

Antithrombotic therapy in atrial fibrillation 2: Reversal strategies and outcomes of major bleeding associated with direct oral anticoagulants compared to warfarin in routine practice: interim results from a multi-centre all-comer cohort

 Assoc. Prof. Francesco Paneni

The immune system in cardiovascular disease: Methyltransferase Set7 drives vascular inflammation and endothelial dysfunction in obesity

 Dr. Matthew Barrett

Cardiomyopathies: Eosinophilic myocarditis in patients on dobutamine therapy: an underappreciated but not uncommon phenomenon

 Dr. Christian Stratz

Mechanisms of platelet activation: Evaluation of immature platelet parameters as compared to  established predictors of platelet reactivity after thienopyridine loading

 

Monday 29 August - 15:30

 Dr. Rudolf Werner

New developments in cardiovascular SPECT and PET: Detection of focal inflammatory CD68-positive macrophage infiltrates by 18F-FDG uptake in a rat model of autoimmune Myocarditis (EAM-model)

 Dr. Chang Wei-Ting

Complications of hypertension: Evaluation of coronary flow velocity by Doppler echocardiography in the treatment of hypertension with the ACEi/ARB: correlation to the histological cardiac fibrosis

 Dr. Charles Ilsley

New aspects on PCI: Prognostic significance of incomplete revascularization and bystander coronary anatomy following percutaneous coronary intervention: an observational study of 6,755 patients with multivessel disease

 Mr. Kasper Gadsboell

Antithrombotic therapy in atrial fibrillation 1: Increased use of oral anticoagulants in patients with atrial fibrillation: Nationwide temporal trends in Denmark from 2005 to 2015

 Dr. Muhammad Aslam

Vascular biology: Impact of the adiponectin paralog CTRP13 on endothelial cells

 Dr. Cho-Kai Wu

Diastolic function: Galectin-3 level and the severity of cardiac diastolic dysfunction using cellular and animal models and clinical indices

 Dr. Andreia Pereira

Improved risk prediction and subsequent action: Net Reclassification index of a genetic risk score and standard Framingham risk stratification in a european population

 Prof. Anetta Undas

Advances in pulmonary embolism: Prothrombotic fibrin clot phenotype is associated with recurrent pulmonary embolism following discontinuation of anticoagulant therapy

 Dr. Jens-Uwe Roehnisch

Coronary revascularisation: how and how much: Transradial vs. transfemoral access in patients with ACS: bleeding complications and outcome

 

Monday 29 August - 10:00

 Ms. Giorgia Maria Bosi

Computer modelling and simulation: A validated computational framework to simulate transcatheter aortic valve implantation in patients before the procedure

 Mr. Arjun Pandey

Lifestyle and blood pressure: The impact of obesity and diet-induced weight loss on non-dippers and circadian BP patterns

 Dr. Muthiah Vaduganathan

PCI complications: Bleeding events and subsequent 30-day and 1-year mortality after percutaneous coronary intervention: a contemporary pooled patient-level analysis from the CHAMPION 

 Dr. Tze-Fan Chao

Comorbidities and atrial fibrillation: Presence of diabetic complications does not incrementally increase risk of ischemic stroke in diabetic patients with atrial fibrillation

 Dr. Yanwen Wang

Ion channels: from the molecular level to integrative biology: Circadian rhythm in heart rate is due to an intrinsic circadian clock in the sinus node

 Mr. Julian Mustroph

Novel pharmacological therapy in chronic heart failure: The CaMKII inhibitor RA123456 attenuates heart failure and prevents ventricular and atrial arrhythmias in vivo

 Dr. Jacob Klein

Prognosis and cost-effectiveness of cardiac rehabilitation: Mortality benefit of cardiac rehabilitation after myocardial infarction in the modern era

 Dr. Keimei Yoshida

Basic mechanisms in pulmonary hypertension: Inhibition of nuclear factor-kappaB-mediated inflammation improves RV function in rats with pulmonary artery banding

 Ms. Caroline Sindet-Pedersen

Insights on thrombosis and anticoagulants: Familial clustering of venous thromboembolism - A Danish nationwide cohort study

 Ms. Charlotte Holst Hansen

Insights on thrombosis and anticoagulants: Markers of thrombin generation in patients with ST-elevation myocardial infarction are associated with long term clinical outcome 

 

Sunday 28 August - 15:30

 Dr. Daniel Rodriguez Munoz

Improving clinical response to CRT: Optimal coupling between vortical flow in left ventricular outflow tract and left ventricular ejection: a result of atrio-ventricular delay optimization

 Prof. Massimo Imazio

Hot issues in pericardial and myocardial disease: Treatment of idiopathic recurrent pericarditis with anakinra. A multicenter randomized controlled clinical trial.

 Dr. Christian Puelacher

Comorbidities in coronary artery disease: what matters?: Combining high-sensitivity cardiac troponin and B-type natriuretic peptide in the detection of exercise-induced myocardial ischemia

 Dr. Pedro Canas da Silva

Current data on TAVI outcomes: Medtronic CoreValve vs Edwards Sapien: a comparative analysis of efficacy, safety and mortality from an eight year nationwide registry

 Dr. Ziad Hijazi

The relevance of biomarkers: a never ending story: Growth differentiation factor 15 is an independent marker of risk of major bleeding in atrial fibrillation: insights from the RE-LY trial

 Dr. Kyriakos Dimitriadis

Metabolic factors and biomarkers: Uric acid levels predict coronary artery disease in essential hypertension: Data from a Greek 8-year-follow-up study 

 Dr. Christian Werner

Cardiac biology and senescence : Telomerase deficiency is associated with impaired diastolic function, mitochondrial dysfunction and increased fibrosis in a murine model of cardiac pressure overload

 Dr. Anusith Tunhasiriwet

Novel ultrasonic techniques : Novel index of right ventricular myocardial stiffness in patients with pulmonary hypertension: correlations with cardiac morphology and who functional class

 

Sunday 28 August - 10:00

 Ms. Yu Jing Mo

The aortic valve: Resolving inconsistencies between gradient and flow measurements by echocardiography in patients with significant aortic valve stenosis and preserved LV ejection fraction

 Prof. Giuseppe Derosa

Drug treatment of hypertension: Results of the ESCAPE trial: an italian, multi-centre, phase IV, randomized, controlled, open-label trial on the effects of canrenone in hypertensive patients

 Dr. Guido Parodi

Factors influencing long term PCI outcomes: Adverse clinical event occurrence beyond one year after an acute coronary syndrome: insights from the RECLOSE 2-ACS study

 Assoc.Prof. Finn Lund Henriksen

Overcoming ventricular arrhythmias and sudden death: Emergency dispatch, global positioning of first responders with distinct roles and automatic external defibrillators - a logistic solution to secure basic life support and defibrillation

 Dr. Sebastiano Sciarretta

Lipids and platelets: C2238 atrial natriuretic peptide molecular variant determines an increased platelet aggregation through the activation of NOX2 and the reduction of cAMP

 Mr. Michal Tkaczyszyn

New targets for biomarkers in heart failure: Adequacy of endogenous erythropoietin levels in anaemic heart failure patients - relationship with disease severity and co-morbidities

 Dr. Ana Rita Marinheiro

Up in smoke: the impact of tobacco use and smoking cessation: Effects of smoking and smoking cessation on twenty-four hour blood pressure

 Dr. Giuseppe Derosa

Improving diagnosis in cardiomyopathies: Cardiac magnetic resonance in arrhythmogenic  right ventricular cardiomyopathy:  combined functional assessment and tissue characterization versus task force criteria. 

 Dr. Jasper Boeddinghaus

Optimising outcomes in acute coronary syndrome: Direct comparison of four very early rule-out strategies for acute myocardial infarction using high-sensitivity cardiac troponin I

 

Saturday 27 August - 12:30

 Mr. Niklas Dyrby Johansen

New technologies in echo-ventricular function and myocardial diseases: Diastolic dysfunction revisited: a new, feasible and unambigious classification predicts major cardiovascular events

 Dr. Amy Elizabeth Burchell

Target organ damage in hypertension: Magnetic resonance imaging as an assessment tool in hypertension

 Mr. Jakob Ledwoch

Optimising primary PCI: Drug eluting stent vs. bare metal stent in acute myocardial infarction complicated by cardiogenic shock - A substudy of the IABP-SHOCK II-trial

 Prof. Oussama Wazni

Management of device complications and lead extraction: are we getting better?: Cardiac implantable electronic device infection: variability in clinical presentation and outcomes in patients with or without previously abandoned leads

 Mr. Kai Knoepp

Angiogenesis: MiR-146a inhibition augments angiogenesis and myocardial regeneration

 Dr. Oscar Miro

Prognostication in heart failure: Predictors of 30-day mortality in patients with acute heart failure at emergency department admission: derivation and validation of the MEESSI-AHF scale

 Dr. Tee Joo Yeo

Interplay between exercise and cardiac pathology: The effect of exercise on the aortic root diameter in young elite athletes with bicuspid aortic valve disease.

 Dr. Alessandro Zorzi

Interplay between exercise and cardiac pathology: Non-ischemic left ventricular scar as a substrate of life-threatening ventricular arrhythmias and sudden cardiac death in competitive athletes

 Mr. Joey Kuijpers

Challenges in congenital heart disease: Aortopathy in various types of adult congenital heart disease

 Dr. Giuseppe Ferrante

Dual antiplatelet therapy: the long and the short of it!: Long term dual antiplatelet therapy after drug eluting stents: a meta-analysis of randomised studies

Moderated Posters Awards 2015

Congratulations to the winners of the Moderated Posters Awards Sessions 2015 !

Overall Winners by topics

 Jeroen Venlet, Netherlands

Ventricular arrhythmias: stratification and treatment: Critical progressive activation delay after premature stimulation is associated with polymorphic ventricular tachycardia in nonischemic cardiomyopathy: results from the Leiden NICM Study

 Akshay Suvas Desai, United States of America

Heart failure therapy: Factors associated with dropout during the run-in period prior to randomization in PARADIGM-HF

 Antonio Brucato, Italy

Prognosis in pericardial disease: Recurrent pericarditis in children and adolescents.A multicentre cohort study

 Ronak Delewi, Netherlands

Post myocardial infarction outcome: Long term myocardial recovery after revascularization for ST-segment elevation myocardial infarction as assessed by cardiac magnetic resonance imaging

 Jerrold Levy, United States of America

Anti-thrombotics in clinical practice: Initial experience with idarucizumab in dabigatran-treated patients requiring emergency surgery or interventon: interim results from the RE-VERSE AD study

 Mahir Karakas, Germany

Advancing the clinical application of biomarkers: Prognostic value of circulating MicroRNAs in patients with coronary artery disease - results from the AtheroGene study

 Shizuya Yamashita, Japan

Treatment of hypercholesterolemia. A vision to the future: Effect of K-877, a potent and selective PPAR alpha modulator (SPPARM alpha), on cholesterol efflux from macrophages in dyslipidemic patients

 Christian Kupatt, Germany

New advances in cardiovascular genetics and gene therapy: Impact of diabetes mellitus on Thymosin B4 mediated therapeutic neovascularization

 Sander Trenson, Belgium

Clinical impact and modulation of endothelial (dys)function:  Altered molecular signature of cardiac microvascular endothelium after chronic pressure overload and transition to heart failure

 Mischa Rijnierse, Netherlands

Developments in nuclear cardiology, prognosis, risk stratification and management strategies: Effect of beta-blocking therapy on cardiac sympathetic nerve function in patients with idiopathic pulmonary arterial hypertension

Winners by sessions

Tuesday 1 September - 15:30

 Jeroen Venlet, Netherlands

Ventricular arrhythmias: stratification and treatment: Critical progressive activation delay after premature stimulation is associated with polymorphic ventricular tachycardia in nonischemic cardiomyopathy: results from the Leiden NICM Study.

 Stephane Fournier, Switzerland

Reperfusion of STEMI: Circadian variation of intracoronary thrombus aspiration efficacy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

 Oana Mirea, Belgium

New techniques and new applications in echocardiography:  Effect of afterload increase on left ventricle mechanical dispersion and electromechanical window.

 Josebe Goirigolzarri Artaza, Spain

New techniques and new applications in echocardiography:  Validation of 2D strain parameters in the diagnosis of acute rejection after heart trasplantation.

 Nico Hartmann, Germany

Outcomes after TAVI: Seven-year outcome after TAVI

 Junjing Su, Denmark

Differentiating pulmonary arterial hypertension from other pulmonary hypertension groups: Impact of atrial contraction on diagnosis of pre- versus post-capillary pulmonary hypertension.

 Lars Wallentin, Sweden

What's next in cardiovascular risk prediction? Biomarker-based risk score for prediction of cardiovascular events in stable coronary heart disease - Experiences from the STABILITY biomarker substudy.

 Jerrold Levy, United States of America

Anti-thrombotics in clinical practice:  Initial experience with idarucizumab in dabigatran-treated patients requiring emergency surgery or interventon: interim results from the RE-VERSE AD study.

 Marc Jolicoeur, Canada

Management in heart failure: new perspectives:  Influence of angina and revascularization in patients with left ventricular systolic dysfunction and coronary artery disease: insights from the STICH trial.

 Shizuya Yamashita, Japan

Treatment of hypercholesterolemia. A vision to the future: Effect of K-877, a potent and selective PPAR alpha modulator (SPPARM alpha), on cholesterol efflux from macrophages in dyslipidemic patients.

 

Tuesday 1 September - 10:00

 S Benedict Freedman, Australia

Antithrombotic prophylaxis in atrial fibrillation: High burden of potentially avoidable stroke from discontinuation of warfarin therapy in non-valvular atrial fibrillation.

 Juliana Reis Pires Martins, Portugal

Acute phase of STEMI:  Revascularization strategies in patients with ST-segment elevation myocardial infarction and multivessel disease in a real world population.

 Alexios Antonopoulos, Greece

Advances in cardiac computed tomography imaging:  Epicardial adipose tissue expansion and differentiation status predict myocardial redox state and coronary calcification.

 Yoshihisa Yamada, Japan

Cardiovascular dysfunction and repair - Roles of inflammation and immune cells: Sphigosine-mono-phosphate (S1P) induces the migration of Muse cells but not non-Muse cells toward the rabbit post-infarct heart and contributes to the improvement of cardiac function and remodeling.

 Benjamin Alos, France

Outcomes after TAVI: Seven-year outcome after TAVI

 Mahir Karakas, Germany

Advancing the clinical application of biomarkers: Prognostic value of circulating MicroRNAs in patients with coronary artery disease - results from the AtheroGene study.

 Tatsunori Takahashi, Japan

Understanding pathophysiology from imaging and functional assessment: Usefulness of optical coherence tomography in determining the mechanisms of myocardial infarction in patients without angiographically demonstrable coronary artery disease.

 Elizabeth Feijen, Netherlands

Ominous signs in heart failure: Time-related cumulative incidence of congestive heart failure after childhood cancer treatment; a DCOG LATER study.

 Hisaki Makimoto, Japan

Hypertension and comorbidities: a challenge of treatment:  Diverge responses of cardiac autonomic function to beta-blocker therapy depending on chronic kidney disease.

 

Monday 31 August - 15:30

 Elmir Omerovic, Sweden

Atrial fibrillation in real world: Atrial fibrillation in patients admitted to coronary care units in western Sweden. focus on obesity and lipotoxicity

 Steen Hansen, Denmark

Pre-hospital phase of STEMI: Increased dissemination of registered AEDs is associated with higher rate of bystander defibrillation in public locations but not in residential areas - a nationwide study.

 Axel Bauer, Germany

Information technology applications in cardiology: Assessment of deceleration capacity from short-term recordings  predicts mortality after myocardial infarction.

 Javier Barallobre-Barreiro, United Kingdom

Extracellular matrix, remodelling and inflammation: Glycoproteomics analysis of cardiac extracellular matrix reveals the presence of decorin fragments with anti-myostatin and anti-fibrotic activity.

 Oliver Husser, Germany

Aortic stenosis - From basics to prognosis: Combining tumor marker carbohydrate antigen 125 and the logistic EuroSCORE improves risk stratification in patients undergoing transcatheter aortic valve implantation.

 Adam Kenneth McDiarmid, United Kingdom

Differentiating physiological adaptation from cardiac pathology in athletes: Athletic cardiac adaptation is secondary to increased myocyte mass.

 Sergio Leonardi, Italy

Prediction models in clinical practice: Implications of different criteria for percutaneous coronary intervention-related myocardial infarction on study results of three large phase III clinical trials: the CHAMPION experience.

 Sanne De Jong, Netherlands

Heart failure: diversity of phenotyping: MicroRNAs as a quantitative and prognostic biomarker of interstitial cardiac fibrosis in pressure overloaded mice.

 Yan Zhang, China, People's Republic of

Hypertension pathophysiology II: Non-invasive central systolic blood pressure not peripheral systolic blood pressure associated with kidney function decline in a chinese community-based population.

 

Monday 31 August - 10:00

 Abdul Shokor Parwani, Germany

Different aspects in management of atrial fibrillation: Relationship between reduced left atrial function and electro-anatomical remodeling in patients undergoing atrial fibrillation ablation.

 Tomasz Mazurek, Poland

Experimental and clinical research in myocardial ischaemia: Inflammatory activity of pericoronary adipose tissue in prediabetic patients with NSTE-ACS.

 Satish Chacko, United States of America

Cardiovascular magnetic resonance - Ischaemic heart disease: Prognostic significance of global myocardial perfusion reserve measured using coronary sinus flow during stress cardiovascular magnetic resonance imaging.

 Christian Kupatt, Germany

New advances in cardiovascular genetics and gene therapy: Impact of diabetes mellitus on Thymosin B4 mediated therapeutic neovascularization.

 Louise Eske Bruun, Denmark

Advances in endocarditis: Socioeconomic status and risk of staphylococcus aureus bacteremia - a danish nationwide cohort study .

 Adrian Cid Menendez, Spain

Impact of smoking cessation on cardiovascular prognosis: myths and reality: Prognostic influence of smoking in patients with an acute myocardial infarction: paradox or confusion? a propensity-score matched analysis.

 Timm Bauer, Germany

Management of procedural risks: Disaster in the cath lab - cardiogenic shock induced by procedure: results from the EHS PCI registry.

 Camilla Hage, Sweden

Diastolic dysfunction: Inflammatory biomarkers predict HF severity and prognosis in patients with heart failure with preserved ejection fraction.

 Xavier Jouven, France

Hypertension treatment: Quality of cardiovascular drugs in street markets and pharmacies in 10 sub-saharan african countries: the seven study.

 

Sunday 30 August - 15:30

 Giuseppe Boriani, Italy

Antibradycardia pacing: Time course of detection of new atrial fibrillation (AF) and AF burden in patients with cardiac implanted electronic devices.

 Federica Ilardi, Italy

Improving antiplatelets regimen and cardioprotection in coronary patients: Rac-1 as a new target to modulate endothelial function and platelet aggregation in diabetes mellitus.

 Colin Stirrat, United Kingdom

Cardiovascular magnetic resonance - Translational: Ultrasmall superparamagnetic particles of iron oxide-enhanced magnetic resonance imaging in the assessment of cellular inflammation after myocardial infarction.

 Gemma Vilahur Garcia, Spain

Diet, lipids and the vasculature: Dyslipidemia impairs high-density lipoprotein cardioprotective effects leading to larger infarcts. HDL-characterization by lipid analysis and differential proteomics.

 Alessandra Frigiola, United Kingdom

Challenges in repaired tetralogy of Fallot: Relation between exercise capacity and skeletal muscle metabolism during exercise in patients with repaired tetralogy of Fallot.

 Jouke Bokma, Netherlands

Challenges in repaired tetralogy of Fallot: QRS fragmentation is superior to QRS duration in the prediction of death or ventricular tachycardia in adults with tetralogy of Fallot.

 Guy De Backer, Belgium

What does epidemiology teach us about cardiovascular risk? Prevalence and management of familial hypercholesterolaemia in the euroaspire iv project.

 Claudio Muneretto, Italy

Current status and future directions of coronary artery bypass grafting: Long term follow-up following total arterial versus conventional and hybrid myocardial revascularisation: a propensity-match analysis.

 Joerg Eiringhaus, Germany

Basic mechanisms in heart failure: Ca-homeostasis in human cardiac hypertrophy and end stage heart failure is directly impacted by modulations of protein phosphatase 1 and -2a activity.

 Moo Young Rhee, Korea, Republic of

Hypertension and haemodynamics: Aorta-to-upper arm pulse wave transit time ratio can predict the risk of coronary artery disease and stroke better than pulse wave velocity.

 

Sunday 30 August - 10:00

 Anna Polewczyk, Poland

Complications in devices: Analysis of efficacy and safety of transvenous leads extraction and long term mortality after procedures in women and men.

 Debbie Kalkman, Netherlands

Knowing more about STEMI and non-STEMI: Comparison of 10-Year follow-up mortality rates in a randomized trial comparing routine invasive versus selective invasive management in patients with non ST-segment elevation acute coronary syndrome.

 Michael Huntgeburth, Germany

What's new in imaging for valvular heart disease? Novel method for determination of mitral regurgitation severity before and after percutaneous edge-to-edge mitral valve repair by contrast echocardiography.

 Sander Trenson, Belgium

Clinical impact and modulation of endothelial (dys)function: Altered molecular signature of cardiac microvascular endothelium after chronic pressure overload and transition to heart failure.

 Milind Desai, United States of America

Advances in cardiomyopathies: Outcomes of hypertrophic cardiomyopathy patients undergoing non-cardiac surgery: A cohort study with matched non hypertrophic cardiomyopathy patients.

 Robert Patrick Giugliano, United States of America

Managing lipids - Statins and beyond: Prospectivev evaluation of cancer in 18,144 patients randomized to ezetimibe vs placebo: a prespecified analysis from the IMPROVE IT trial.

 Yusuke Tomoi, Japan

Assessing percutaneous treatment options for PAD: Optimal revascularization strategy for in-stent occlusion after femoro-popliteal stenting.

 Konstantinos Toutouzas, Greece

Myocardial function: The impact of left ventricular function and balloon aortic valvuloplasty on paravalvular leakage in patients undergoing TAVI.

 Lorenzo DiCarlo, United Kingdom

Hypertension: devices and interventions: Transforming the information highway for the clinical management of blood pressure using an ambulatory setting, objective assessment, and digital communication.

 

Saturday 29 August - 12:30

 Damien Voilliot, France

Updates on ICD therapy: Primary prevention indication for implantable cardioverter-defibrillator  in post infarct patients: the value of myocardial infarction scar characterization by magnetic resonance imaging.

 Ronak Delewi, Netherlands

Post myocardial infarction outcome: Long term myocardial recovery after revascularization for ST-segment elevation myocardial infarction as assessed by cardiac magnetic resonance imaging.

 Mischa Rijnierse, Netherlands

Developments in nuclear cardiology, prognosis, risk stratification and management strategies: Effect of beta-blocking therapy on cardiac sympathetic nerve function in patients with idiopathic pulmonary arterial hypertension.

 Bram Trachet, Switzerland

News in cardiac anatomy: Branch-related ruptures cause intramural hematoma and dissecting abdominal aortic aneurysm in angiotensin II-infused ApoE -/- mice.

 Antonio Brucato, Italy

Prognosis in pericardial disease: Recurrent pericarditis in children and adolescents.A multicentre cohort study.

 Nobutaka Ikeda, Japan

From pre-diabetes to vascular complications: Impact of serum 1,5-anhydro-d-glucitol level on prediction of major adverse cardiac and cerebrovascular events.

 Yae Matsuo, Japan

Percutaneous non-coronary techniques for stroke prevention: Long term result of the left atrial appendage closure for stroke prevention in single high volume center.

 Akshay Suvas Desai, United States of America

Heart failure therapy: Factors associated with dropout during the run-in period prior to randomization in PARADIGM-HF.

 Jan Vaclavik, Czech Republic

Hypertension pathophysiology I: Hypertension control and medication burden in patients with additional risk factors in central and eastern europe.

 

Moderated Posters Awards 2014

Taisuke Ishikawa, Japan

Ling Li Teo, Singapore

Ralph Stephan Von Bardeleben, Germany

Karolina Szummer, Sweden

Tim Van de Hoef, Netherlands

Baris Gencer, Switzerland

Grzegorz Bilo, Italy

Kazuhiro Matsuo, Japan

Murray Matangi, Canada

Moderated Posters Awards 2013

Spescha Remo

Perazzolo Marra Martina

Khalid Usman

La Gerche Andre

Paikin Jeremy

Menezes Alves Da Costa Leandro

Leening Maarten

Lourenco Patricia

Igland Jannicke

Segreti Luca

Alraies Chadi

Porta Sanchez Andreu

Verloop Willemien

Bromage Dan

Ujiie Yuichi

Moderated Posters Awards 2012

Sebastiaan Piers

Sebastian Szardien

Alexander Lauten

Constantinos O'Mahony

Juergen Leick

Antonios Antoniadis

Jef Geens

Ismo Anttila

David Erlinge

Pierpaolo Pellicori

Bruna Gigante

Takashi Yamada

Peter Kolkhof

Marrian Gyongyosi

 

Moderated Posters Awards 2011

Christian Ukena

Yuan-Hung Liu

Liza Thomas

Gaetano Nucifora

Lelane Van Der Poel

Gaetano Maria De Ferrari

Toshinari Onishi

Kim Lamont

Guillaume Jondeau

Massimiliano Palazzini

Carsten Skurk

Mary N Sheppard

Erik Tandberg Askevold

 

Moderated Posters Awards 2010

Alberto Bouzas Mosquera

Felix Woitek

Milos Taborsky

Aaron Kee Fui Wong

Daphne Babalis

Nikolaos Bonaros

Giovanna Liuzzo

Navin Chandra

Anselm Kai Gitt

Caroline Veltman

Yoshiji Yamada

Massimo Lacoviello

Philipp Stieger

Carolyn Sp Lam

 

Moderated Posters Awards 2009

Robert Fisher

Susanne Brenner

Mario Previtali

Enrique Santas

Jun Ni

Christian Templin

Bimmer Claessen

Ioannis Laoutaris

Javier Lopez-Diaz

Gianranco Parati

Matteo Cameli

Piotr Musialek

Yvette Van Gestel

Thomas Pilgrim

 

Moderated Posters Awards 2008

Paola Meregalli

Yu Ting Tan

Daniel Fernadez Berges

Anastasios Athanasiadis

Alessandra Serio

Rene A Tio

Renato Lopes

Nick Clappers

John Eikelboom

Danilo Neglia

David Busseuil

Canan Nebigil

Robert Gerber

Anders Sahlen

Robert Doughty

 

Moderated Posters Awards 2007

Stephan Jacobs

Birke Schneider

Stavros Chrysostomakis

Laurent Louis Andre de Kerchove

Fabien Hyafil

Masaya Tanno

Roman Arnold

Stephan Gielsen

Mateusz Orzalkiewicz

Fausto Rigo

Martyn Farrer

Nika Skoro-Sajer

Alexander Staudt

Dorothea Siegel-Axel